Response to "Treating Vasospasm with IV Milrinone: RELAX (the Vessel) or DON'T DO IT!"
Neurocrit Care
.
2023 Oct;39(2):549.
doi: 10.1007/s12028-023-01790-6.
Epub 2023 Jul 11.
Authors
Steven Deem
1
2
,
Sarah Livesay
3
4
,
Miriam M Treggiari
5
Affiliations
1
Neurocritical Care Unit, Swedish Medical Center, Seattle, WA, USA. sdeem@uw.edu.
2
Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA. sdeem@uw.edu.
3
Department of Anesthesiology and Pain Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA.
4
College of Nursing, Rush University, Chicago, IL, USA.
5
Department of Anesthesiology, Duke University Medical School, Durham, NC, USA.
PMID:
37434102
DOI:
10.1007/s12028-023-01790-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Milrinone* / therapeutic use
Subarachnoid Hemorrhage* / complications
Subarachnoid Hemorrhage* / drug therapy
Vasodilator Agents / therapeutic use
Substances
Milrinone
Vasodilator Agents